Participants
depression, weight loss, SD
DISORDERS
This randomized clinical trial was registered in the Iranian Clinical Trial registry under number IRCT 20180523039802N2. The target population consisted of all women whose BMI was higher than 35 (mean ± SD = 38/47 ± 23/54) and aged 25 to 45 years old (mean ± SD = 36.14 ± 10.32) who underwent sleeve gastrectomy in 2020 during the COVID-19 period. The inclusion criteria were receiving sleeve gastrectomy between 18 to 24 months ago, having insufficient weight loss and BMI between 35 to 40 after surgery, and having comorbidities and any psychological disorders such as depression [